KBC Groep NV (KBC)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 110.80 |
|---|---|
| 52-week range | 99.74 – 134.95 |
| Return, 1 month / 3 months | −16.7% / −9.7% |
| Return, 1 year / 3 years | +14.4% / +150.5% |
| Trend | Below its 200-day average |
| RSI (14) | 22 |
| Volatility (1 year) | 22.4% |
| Worst drawdown (1 year) | -17.6% |
| Average daily value traded | 48.76M EUR |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KBC Groep is a Belgian banking and insurance group based in Brussels. It provides retail and private banking services, lending, savings and payment products, along with insurance for individuals and businesses. Its customers include households, small and medium-sized enterprises and larger corporate clients, served mainly in Belgium and in several Central and Eastern European countries where the group operates through local banking and insurance businesses.
KBC Groep NV trades under the code KBC on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KBC Groep NV (KBC) trades on the Euronext Brussels in Belgium. It last closed at EUR 110.80 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 18 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.4% and over the last three months it fell 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.4% | ||
| From 52-week high | -17.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.7% | ||
| 6-month return | -0.4% | ||
| 12-month return, skipping the last month | 37.2% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.6% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 48.76M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 79 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −8.2% |
|---|---|
| 1 month | −16.7% |
| 3 months | −9.7% |
| 6 months | −0.4% |
| 1 year | +14.4% |
| 3 years | +150.5% |
| 5 years | +108.2% |
Signals
| 50-day / 200-day average | 128.20 / 117.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Nov 2026 | EUR 1.0000 |
| 18 May 2026 | EUR 4.1000 |
| 5 Nov 2025 | EUR 1.0000 |
| 6 May 2025 | EUR 3.1500 |
| 12 Nov 2024 | EUR 1.0000 |
| 27 May 2024 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.